Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick J Flower

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|February 1, 2013
Pharmacology 2.0Roderick J Flower
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
In vitro cyclo-oxygenase expression and activity protocols: Introduction to Part IRoderick J Flower
British Journal of Pharmacology|April 7, 2019
Oiling the wheels of discoveryRoderick J Flower
The Journal of Experimental Medicine|March 9, 2005
Controlling inflammation: a fat chance?Roderick J Flower, Mauro Perretti
European Journal of Pharmacology|August 18, 2019
Loss of hypothermic and anti-pyretic action of paracetamol in cyclooxygenase-1 knockout mice is indicative of inhibition of cyclooxygenase-1 variant enzymesSamir S Ayoub, Roderick J Flower
Frontiers in Pharmacology|November 30, 2017
The Anti-allergic Cromones: Past, Present, and FutureAjantha Sinniah, Samia Yazid, Roderick J Flower
Memorias Do Instituto Oswaldo Cruz|June 18, 2005
An overview of the effects of annexin 1 on cells involved in the inflammatory processAhmad M Kamal, Roderick J Flower, Mauro Perretti
Trends in Pharmacological Sciences|August 19, 2007
Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?Saul Yedgar, Miron Krimsky, Yuval Cohen, et al.
British Journal of Pharmacology|June 16, 2004
Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophagesSimon Yona, Julia C Buckingham, Mauro Perretti, et al.
European Journal of Pharmacology|November 4, 2008
The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS)Christopher Bolton, Gwen S Scott, Terence Smith, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|February 1, 2013
Pharmacology 2.0Roderick J Flower
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
In vitro cyclo-oxygenase expression and activity protocols: Introduction to Part IRoderick J Flower
British Journal of Pharmacology|April 7, 2019
Oiling the wheels of discoveryRoderick J Flower
The Journal of Experimental Medicine|March 9, 2005
Controlling inflammation: a fat chance?Roderick J Flower, Mauro Perretti
European Journal of Pharmacology|August 18, 2019
Loss of hypothermic and anti-pyretic action of paracetamol in cyclooxygenase-1 knockout mice is indicative of inhibition of cyclooxygenase-1 variant enzymesSamir S Ayoub, Roderick J Flower
Frontiers in Pharmacology|November 30, 2017
The Anti-allergic Cromones: Past, Present, and FutureAjantha Sinniah, Samia Yazid, Roderick J Flower
Memorias Do Instituto Oswaldo Cruz|June 18, 2005
An overview of the effects of annexin 1 on cells involved in the inflammatory processAhmad M Kamal, Roderick J Flower, Mauro Perretti
Trends in Pharmacological Sciences|August 19, 2007
Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?Saul Yedgar, Miron Krimsky, Yuval Cohen, et al.
British Journal of Pharmacology|June 16, 2004
Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophagesSimon Yona, Julia C Buckingham, Mauro Perretti, et al.
European Journal of Pharmacology|November 4, 2008
The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS)Christopher Bolton, Gwen S Scott, Terence Smith, et al.
Pageof 7